Search by Drug Name or NDC

NDC 60505-0251-01 tizanidine 2 mg/1 Details

tizanidine 2 mg/1

tizanidine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Apotex Corp.. The primary component is TIZANIDINE HYDROCHLORIDE.

MedlinePlus Drug Summary

Tizanidine is used to relieve the spasms and increased muscle tone caused by multiple sclerosis (MS, a disease in which the nerves do not function properly and patients may experience weakness, numbness, loss of muscle coordination and problems with vision, speech, and bladder control), stroke, or brain or spinal injury. Tizanidine is in a class of medications called skeletal muscle relaxants. It works by slowing action in the brain and nervous system to allow the muscles to relax.

Related Packages: 60505-0251-01
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Tizanidine

Product Information

NDC	60505-0251
Product ID	60505-0251_35ea6051-a0fd-835e-472c-ea92db999c7e
Associated GPIs	75100090100310
GCN Sequence Number	027447
GCN Sequence Number Description	tizanidine HCl TABLET 2 MG ORAL
HIC3	H6H
HIC3 Description	SKELETAL MUSCLE RELAXANTS
GCN	14690
HICL Sequence Number	011582
HICL Sequence Number Description	TIZANIDINE HCL
Brand/Generic	Generic
Proprietary Name	tizanidine
Proprietary Name Suffix	n/a
Non-Proprietary Name	tizanidine
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	2
Active Ingredient Units	mg/1
Substance Name	TIZANIDINE HYDROCHLORIDE
Labeler Name	Apotex Corp.
Pharmaceutical Class	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA076533
Listing Certified Through	2024-12-31

Package

NDC 60505-0251-01 (60505025101)

Pricing Information	N/A
NDC Package Code	60505-0251-1
Billing NDC	60505025101
Package	100 TABLET in 1 BOTTLE (60505-0251-1)
Marketing Start Date	2004-01-16
NDC Exclude Flag	N